Patents Assigned to Northern Antibiotics Oy
  • Patent number: 9067974
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: June 30, 2015
    Assignee: Northern Antibiotics OY
    Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
  • Publication number: 20140134669
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Application
    Filed: December 13, 2013
    Publication date: May 15, 2014
    Applicant: Northern Antibiotics Oy
    Inventors: Martti Sakari VAARA, Timo Ilmari VAARA
  • Patent number: 8680234
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Grant
    Filed: July 23, 2010
    Date of Patent: March 25, 2014
    Assignee: Northern Antibiotics Oy
    Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
  • Publication number: 20100292136
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Application
    Filed: July 23, 2010
    Publication date: November 18, 2010
    Applicant: Northern Antibiotics OY
    Inventors: Martti Sakari VAARA, Timo Ilmari Vaara
  • Patent number: 7807637
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: October 5, 2010
    Assignee: Northern Antibiotics Oy
    Inventors: Martti Sakari Vaara, Timo Ilmari Vaara
  • Publication number: 20080287345
    Abstract: The present invention relates to a polymyxin derivative wherein R1, R2 and R3 are optional and R1, R2, R3, R5, R8 and R9 are cationic or neutral amino acid residues selected so that the total number of positive charges at physiological pH is at least two but no more than three; and to a combination product comprising at least two such derivatives.
    Type: Application
    Filed: August 10, 2007
    Publication date: November 20, 2008
    Applicant: Northern Antibiotics Oy
    Inventors: Martti Sakari Vaara, Timo Ilmari Vaara